| CD24 is a potential immunotherapeutic target for mantle cell lymphoma JÁ Freile, N Ustyanovska Avtenyuk, MG Corrales, HJ Lourens, G Huls, ... Biomedicines 10 (5), 1175, 2022 | 24 | 2022 |
| CD20 positive CD8 T cells are a unique and transcriptionally-distinct subset of T cells with distinct transmigration properties M Vlaming, V Bilemjian, JÁ Freile, HJ Lourens, N van Rooij, G Huls, ... Scientific Reports 11 (1), 20499, 2021 | 19 | 2021 |
| High loading efficiency and controlled release of bioactive immunotherapeutic proteins using vaterite nanoparticles G Choukrani, J Álvarez Freile, NU Avtenyuk, W Wan, K Zimmermann, ... Particle & Particle Systems Characterization 38 (7), 2100012, 2021 | 15 | 2021 |
| The novel immune checkpoint GPR56 is expressed on tumor-infiltrating lymphocytes and selectively upregulated upon TCR signaling V Bilemjian, MR Vlaming, J Álvarez Freile, G Huls, M De Bruyn, E Bremer Cancers 14 (13), 3164, 2022 | 12 | 2022 |
| Whispering Gallery Modes-based biosensors for real-time monitoring and binding characterization of antibody-based cancer immunotherapeutics JA Freile, G Choukrani, K Zimmermann, E Bremer, L Daehne Sensors and Actuators B: Chemical 346, 130512, 2021 | 10 | 2021 |
| A luminescence-based method to assess antigen presentation and antigen-specific T cell responses for in vitro screening of immunomodulatory checkpoints and … J Álvarez Freile, Y Qi, L Jacob, MF Lobo, HJ Lourens, G Huls, E Bremer Frontiers in Immunology 14, 1233113, 2023 | 1 | 2023 |
| Tumor infiltrating CD8/CD103/TIM-3-expressing lymphocytes in epithelial ovarian cancer co-express CXCL13 and associate with improved survival M Vlaming, V Bilemjian, JÁ Freile, V Melo, A Plat, G Huls, HW Nijman, ... Frontiers in Immunology 13, 1031746, 2022 | 1 | 2022 |
| VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responses Y Lin, G Choukrani, L Dubbel, L Rockstein, JA Freile, Y Qi, V Wiersma, ... Experimental Hematology & Oncology 13 (1), 35, 2024 | | 2024 |
| Navigating the path of Cancer Immunotherapeutics: Novel Targets and Innovative Development Tools JÁ Freile | | 2024 |
| 993 InteractPrint predicts clinically meaningful interactions between cancer epithelial cells and immune cells: lessons from a single-cell breast cancer atlas L Xu, K Saunders, H Knutsdottir, K Chen, J Maués, C Hodgdon, ER Torres, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 988 B-cell receptor (BCR) repertoire and antibody recognition analysis of melanoma patients treated with neoadjuvant immune checkpoint blockade (ICB) M Zelazowska, S Paul, J Plummer, M Chelvanambi, B Helmink, R Witt, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| High Loading Efficiency and Controlled Release of Bioactive Immunotherapeutic Proteins Using Vaterite Nanoparticles (Part. Part. Syst. Charact. 7/2021). G Choukrani, J Álvarez Freile, NU Avtenyuk, W Wan, K Zimmermann, ... Particle & Particle Systems Characterization 38 (7), 2021 | | 2021 |
